S2C6:Clinical Trial Statistics

原文始发于微信公众号(化学音乐文化):S2C6:Clinical Trial Statistics

S2C6:Clinical Trial Statistics

JanFourman,PhD, EdD,MBA, MSRA

S2C6:Clinical Trial Statistics

Eli Lilly – Pharma registration for diabetes/endocrine, women/men’s health, neural science, oncology, bone/muscle/joint therapeutic areas – 5 years
Eli Lilly – Pharmacovigilance – 7 years
Eli Lilly – Regulatory Intelligence – 3 Years
Purdue University and Roche Diagnostics – Teaching global pharma development, Africa and US
Consultant for Indiana Technical Assistance Program
Invited conference speaker
Published author

S2C6:Clinical Trial Statistics
S2C6:Clinical Trial Statistics


Clinical Trial Statistics

Utilizing Statistical Concepts to Make Key Decisions when Designing Clinical Trials:

Introduce clinical trial statistics and their relevance to designing trials

Understand terminology

identify information to compute a sample size

understand how statistical tests are selected

Emphasize the importance of an ongoing collaboration between the statistician and the physician